Stockscreener 앱 받기
1.45
5.84%
0.08
시간 외 거래:
1.51
0.06
+4.14%
전일 마감가:
$1.37
열려 있는:
$1.36
하루 거래량:
198.65K
Relative Volume:
0.27
시가총액:
$7.92M
수익:
-
순이익/손실:
$-6.91M
주가수익비율:
-0.4448
EPS:
-3.26
순현금흐름:
$-6.14M
1주 성능:
-6.45%
1개월 성능:
-30.62%
6개월 성능:
-44.87%
1년 성능:
-56.85%
1일 변동 폭
$1.3218
$1.4776
1주일 범위
$1.3218
$1.6991
52주 변동 폭
$1.15
$23.80
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
GLMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.45 | 7.92M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-05-22 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | 개시 | Craig Hallum | Buy |
| 2020-01-30 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-12-02 | 개시 | Canaccord Genuity | Buy |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-08-02 | 재확인 | Maxim Group | Buy |
| 2018-07-13 | 개시 | Stifel | Buy |
| 2018-07-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-06-12 | 재확인 | H.C. Wainwright | Buy |
| 2018-03-15 | 업그레이드 | Maxim Group | Hold → Buy |
| 2018-02-14 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2018-02-12 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 개시 | ROTH Capital | Buy |
| 2017-08-08 | 재확인 | H.C. Wainwright | Buy |
| 2017-07-31 | 재확인 | Maxim Group | Buy |
| 2016-08-01 | 재확인 | Maxim Group | Buy |
| 2016-07-06 | 재개 | ROTH Capital | Buy |
| 2016-03-28 | 재개 | H.C. Wainwright | Buy |
| 2015-06-23 | 개시 | H.C. Wainwright | Buy |
| 2015-05-06 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Galmed Pharmaceuticals Ltd 주식(GLMD)의 최신 뉴스
Can Galmed Pharmaceuticals Ltd. hit a new high this monthFree Daily Volume Spike Trading Signals - Newser
Historical volatility pattern of Galmed Pharmaceuticals Ltd. visualizedFree Capital Preserving Trade Plan Templates - Newser
Analyzing Galmed Pharmaceuticals Ltd. with multi timeframe chartsSmart Entry Signals for Active Traders - Newser
Is Galmed Pharmaceuticals Ltd. Stock a Good Fit for Conservative InvestorsFree Capital Preserving Trade Plan Templates - Newser
What machine learning models say about Galmed Pharmaceuticals Ltd.Buy and Hold Return Summary with Charts - Newser
Is Galmed Pharmaceuticals Ltd. still worth holding after the dipTriple Digit Gain Opportunity Watchlist - Newser
Short Interest in Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Expands By 49.9% - Defense World
Volatility clustering patterns for Galmed Pharmaceuticals Ltd.5-Year Price Trend Summary and Analysis - Newser
Quantitative breakdown of Galmed Pharmaceuticals Ltd. recent moveVolume Spike Detection for Early Breakouts - Newser
What moving averages say about Galmed Pharmaceuticals Ltd.Swing Trade Watchlist with Entry Zones - Newser
How Galmed Pharmaceuticals Ltd. stock performs during market volatilityHistorical Market Behavior and Trend Summary - Newser
Short Term Trend Reversal in Galmed Pharmaceuticals Ltd. PossibleHigh Accuracy Alerts for ROI Traders Detected - beatles.ru
Technical signs of recovery in Galmed Pharmaceuticals Ltd.High Conviction Stock Long-Term Summary - Newser
Investors Hope for Bounce in Galmed Pharmaceuticals Ltd. After Selloff - metal.it
Why Galmed Pharmaceuticals Ltd. stock attracts strong analyst attentionNear-Term Market Opportunity Forecast Sheet - Newser
Is it the right time to buy Galmed Pharmaceuticals Ltd. stockMaximize returns with strategic portfolio planning - Jammu Links News
How does Galmed Pharmaceuticals Ltd. compare to its industry peersHigh-octane financial growth - Jammu Links News
What is Galmed Pharmaceuticals Ltd. company’s growth strategyConsistently outstanding ROI - Jammu Links News
What are Galmed Pharmaceuticals Ltd. company’s key revenue driversMaximize portfolio value with expert tips - Jammu Links News
Is Galmed Pharmaceuticals Ltd. stock overvalued or undervaluedAccelerated wealth expansion - Jammu Links News
What drives Galmed Pharmaceuticals Ltd. stock priceUnlock daily stock market insights for success - Jammu Links News
Is Galmed Pharmaceuticals Ltd. a good long term investmentUnmatched profit potential - Jammu Links News
Should I hold or sell Galmed Pharmaceuticals Ltd. stock in 2025Accelerated financial growth - Jammu Links News
What are analysts’ price targets for Galmed Pharmaceuticals Ltd. in the next 12 monthsAccess high-quality stock research instantly - Jammu Links News
What is the risk reward ratio of investing in Galmed Pharmaceuticals Ltd. stockUnmatched market performance - Jammu Links News
Why is Galmed Pharmaceuticals Ltd. stock attracting strong analyst attentionFree Expert Stock Watchlist - Jammu Links News
When is Galmed Pharmaceuticals Ltd. stock expected to show significant growthBuild a winning investment portfolio - Jammu Links News
Identifying reversal signals in Galmed Pharmaceuticals Ltd.Deep Learning Stock Forecast for Investors - Newser
What catalysts could drive Galmed Pharmaceuticals Ltd. stock higher in 2025Exceptional gains - Jammu Links News
Galmed Pharmaceuticals (NASDAQ:GLMD) Cut to Sell at Wall Street Zen - Defense World
What are the technical indicators suggesting about Galmed Pharmaceuticals Ltd.Achieve breakthrough financial results - Jammu Links News
What is the dividend policy of Galmed Pharmaceuticals Ltd. stockMarket Forecast Signals For Fast Growth - Jammu Links News
Real time pattern detection on Galmed Pharmaceuticals Ltd. stockIntraday Strategy with Real Time Monitoring - Newser
Galmed Pharmaceuticals Ltd. Recovers — But Is It SustainableSwing Trading Plan With Smart Signals in Review - metal.it
Published on: 2025-07-29 06:42:13 - Newser
Galmed Pharmaceuticals Ltd (GLMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):